PharmaMar

LURBINECTEDIN (PM1183) + DOXORUBICIN

Biodrugs/ Drugs
Autoimmune & Inflammation
Digestive System
Small Cell lung cancer
3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical